|
⚲
|
| Acetylon Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001469566 |
| Sale | 2009-07-24 ($8.0 M Offered, $7.2 M Sold) |
| Fund | |
| Phone | 6174352664 |
| Address | c/o National Registered Agents, Inc Boston, 02210 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Walter Ogier | |
| James Bradner | |
| Elena Prokupets | |
| Bruce Downey | |
| Kenneth Anderson | |
| Marc Cohen |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Dial Sara R.
✚
|
0.0 | |
|
Diamond Matthew C
✚
|
0.0 | |
|
Diaspora Ventures, LP - C4
✚
|
0.0 | |
|
DiBona Jason
✚
|
0.0 | |
|
Dicciani Nance K
✚
|
0.0 | |
|
Dichter Kenneth H
✚
|
0.0 | |
|
Dick John W
✚
|
0.0 | |
|
Staffieri Brett
✚
|
0.0 | |
|
Stage Venture Partners III, LP
✚
|
0.0 | |
|
DiagNose Seed SPV 01 Dec 2022 a Series of CGF2021 LLC
✚
|
0.0 |